MedTrace Logo

Special Drug Use Investigation of Ciproxan Injection in Pediatrics

NCT02555059 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 48

Last updated 2020-02-28

No results posted yet for this study

Summary

The objective in this study is collecting post-marketing information on the safety and efficacy of Ciproxan injection under the routine clinical practice.

Conditions

  • Cystitis / Pyelonephritis / Cystic Fibrosis / Anthrax

Interventions

DRUG

Cipro (Ciprofloxacin, BAYQ3939)

Treatment parameters following the physician's decision based on the summary of product characteristics.

Sponsors & Collaborators

Principal Investigators

  • Bayer Study Director · Bayer

Eligibility

Max Age
14 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-07-15
Primary Completion
2018-12-17
Completion
2019-06-13

Countries

  • Japan

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02555059 on ClinicalTrials.gov